Mahamaya Lifesciences IPO Sees Moderate Demand, Subscribed 1.63x on Day 3

Mahamaya Lifesciences Limited's initial public offering (IPO) has demonstrated moderate investor interest through its third day of subscription. The stock price band is set at ₹108–₹114 per share. The ₹70.44 crore IPO reached 1.63 times by 5:39:33 PM on day three.
 Mahamaya Lifesciences IPO non-institutional investors segment leads with strong 3.63 times subscription. Qualified institutional buyers demonstrate moderate participation at 1.19 times. Individual investors display moderate interest at 1.02 times.

Mahamaya Lifesciences IPO subscription reached moderate 1.63 times on day three. It was led by Non-Institutional Investors (3.63x), Qualified Institutional Buyers Ex-Anchor (1.19x), and Individual Investors (1.02x). Total applications reached 1,037.

Subscription Status of Mahamaya Lifesciences IPO:

Here are the subscription details for Mahamaya Lifesciences IPO as of Day 3 (November 13, 2025, 5:39:33 PM):

Mahamaya Lifesciences IPO Reservation

Key Highlights - Day 3:

• Overall subscription reached moderate 1.63 times, showing improvement from day two’s 0.34 times.
• Qualified institutional buyers (ex-anchor) showing steady performance at 1.19 times, building from day two’s 0.65 times, indicating early institutional participation.
• Individual investors displaying consistent participation at 1.02 times, building from day two’s 0.20 times, indicating improving retail response.
• Total applications reached 1,037, showing moderate investor participation for this SME IPO.
• Cumulative bid amount reached ₹76.54 crores, exceeding the net offer size of ₹66.91 crores (excluding anchor and market maker portions).

Mahamaya Lifesciences IPO - Day 2 Subscription at 0.34 Times

Key Highlights - Day 2:

• Overall subscription reached limited 0.34 times, showing minor improvement from day one’s 0.11 times.
• Qualified institutional buyers showing initial performance at 0.65 times, indicating early participation.
• Individual investors showing steady participation at 0.20 times, indicating cautious retail sentiment.

Mahamaya Lifesciences IPO - Day 1 Subscription at 0.11 Times

Key Highlights - Day 1:

• Overall subscription reached minimal 0.11 times, showing slow initial investor response.
• Qualified institutional buyers showing no participation at 0.00 times, indicating bids yet to open.
• Non-institutional investors displaying low confidence at 0.35 times, showing early HNI activity.
• Individual investors showing weak performance at 0.07 times, indicating limited retail interest.

About Mahamaya Lifesciences Limited

 Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of crop protection products and bioproducts for soil and crop health management. The company manufactures pesticide formulations, supplies bulk products to agrochemical companies and MNCs, and markets branded formulations globally.
 The company exports to multiple international markets including Egypt, Jordan, UAE, Ethiopia, and Turkey. Its product portfolio includes technical sales, bulk formulations, and own brands such as MAYAMRIT GR, MAYAMRIT SL, and MAYAGIBB.